are bispecific antibodies that activate T cells by targeting CD3 and that have been approved for the treatment of triple-class–exposed relapsed or refractory multiple myeloma. A total of 94 ...
People are living longer, living better with multiple myeloma. But I think for the vast majority of people who are diagnosed, we still don't have a curative treatment for multiple myeloma, so that, to ...
A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma ...
Study reveals VLCFA metabolism as a key target in multiple myeloma, enhancing drug efficacy and overcoming resistance.
Medpage Today on MSN3mon
Overcoming the Challenges of Applying CAR T-Cell Therapy to Solid TumorsSubsequently, CAR T-cell therapies for multiple myeloma received ... T-cell engager (BiTE) binds DLL3 on cancer cells and CD3 ...
In patients with multiple myeloma, combined vincristine, doxorubicin and dexamethasone (VAD) is the most frequently used induction therapy before autologous stem-cell transplantation (ASCT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback